InMed Pharmaceuticals amends share purchase agreement
InMed Pharmaceuticals amended an agreement with original and new investors to sell additional common stock and pre-funded warrants. The transaction is anticipated to close in the fourth quarter of 2026.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day